Patheon news

Patheon, Inc. (Patheon) is a provider of commercial manufacturing and pharmaceutical development services (PDS) of prescription (Rx) and over-the-counter (OTC) drugs to the international pharmaceutical industry based at Mississauga,Canada

Canadian drugmaker loses $6 million in third quarter

Canadian drugmaker loses $6 million in third quarter

TheChronicleHerald.ca - 2 minutes ago
TORONTO (CP) — Drugmaker Patheon produced "disappointing" third-quarter results Monday as revenues plunged 15.7 per cent from a slowdown at the company's Puerto Rico operations and drug ...

Canadian Economic Calendar

Canadian Economic Calendar

Metro Canada - Toronto - 13 hours ago
TORONTO - Drugmaker Patheon (TSX:PTI) produced "disappointing" third-quarter results Monday as revenues plunged 15.7 per cent from a slowdown at the company's Puerto Rico operations and drug ...

DJ Canada Hot Stocks To Watch: Patheon, Inmet, 20-20, Pengrowth

DJ Canada Hot Stocks To Watch: Patheon, Inmet, 20-20, Pengrowth

Trading Markets - 8 minutes ago
TORONTO, Sep 14, 2009 (Dow Jones Commodities News Select via Comtex) -- PNHNF | Quote | Chart | News | PowerRating -- Listed below are the stocks expected to move during Monday's trading session ...

JLL says no sale

JLL says no sale

European Venture Capital Journal - 46 minutes ago
Private equity firm JLL Partners has announced it is not in talks with Swiss-based Lonza to tell its majority stake in Canadian drugmaker Patheon. Lonza recently launched a US$460m bid for Patheon ...

Deals of the day -- mergers and acquisitions

Deals of the day -- mergers and acquisitions

Reuters - 11 hours ago
** JLL Partners repeated its stance that it would not extend its offer to acquire Canadian drugmaker Patheon Inc (PTI.TO). [ID:nN27305610] ** NYSE Euronext (NYX.N) said the trans-Atlantic stock ...

Deals of the day -- mergers and acquisitions

Deals of the day -- mergers and acquisitions

Reuters India - 6 minutes ago
** JLL Partners repeated its stance that it would not extend its offer to acquire Canadian drugmaker Patheon Inc (PTI.TO: Quote, Profile, Research). [ID:nN27305610] ** NYSE Euronext (NYX.N: Quote ...

Syndicate content